The slowly activating delayed rectifier K ϩ current, I Ks , is an important modulator of cardiac action potential repolarization. Here, we describe a novel benzodiazepine, [L-364,373 [(3-R)
voltages near the threshold for normal channel activation, caused by a shift in the voltage dependence of I Ks activation. R-L3 slowed the rate of I Ks deactivation and shifted the halfpoint of the isochronal (7.5 sec) activation curve for I Ks by Ϫ16 mV at 0.1 M and Ϫ24 mV at 1 M. R-L3 had similar effects on cloned KvLQT1 channels expressed in Xenopus laevis oocytes but did not affect channels formed by coassembly of KvLQT1 and hminK subunits. These findings indicate that the association of minK with KvLQT1 interferes with the binding of R-L3 or prevents its action once bound to KvLQT1 subunits.
Repolarization from the plateau phase of the AP in ventricular myocytes is controlled by a delicate balance between inward and outward currents in the setting of a high membrane resistance. Important outward currents that determine repolarization are I Kr and I Ks (Sanguinetti and Jurkiewicz, 1990) . Several class III antiarrhythmic agents block I Kr and thereby prolong APD and the QT interval on the electrocardiogram. Excessive APD prolongation by these drugs causes LQT, which is associated with torsades de pointes, a ventricular tachyarrhythmia that can degenerate into ventricular fibrillation and cause sudden death.
LQT can also be inherited. The finding that mutations in HERG, the gene that encodes I Kr channels, cause inherited LQT Sanguinetti et al., 1995 Sanguinetti et al., , 1996a provided a mechanistic link between acquired LQT and one form of inherited LQT. The most common form of LQT is caused by mutations in KvLQT1, a novel K ϩ channel gene . Expression of KvLQT1 in either Xenopus laevis oocytes or mammalian cell lines induced a K ϩ current with biophysical properties unlike any known cardiac K ϩ current. Coexpression of KvLQT1 with minK induced a current that was essentially identical to cardiac I Ks , indicating that KvLQT1 and minK proteins coassemble to form I Ks channels (Barhanin et al., 1996; Sanguinetti et al., 1996b) . Thus, dysfunction of either I Kr or I Ks can increase the risk of cardiac arrhythmia and sudden death.
An activator of I Kr or I Ks channels might be useful for the treatment of LQT that results from excessive pharmacological block of these channels or from mutations in the genes that encode the channel proteins. We previously described the properties of L-735,821, a benzodiazepine that is a potent and selective stereospecific blocker of cardiac I Ks . In this study and one preliminary report (Salata et al., 1997) , we describe another 1,4 benzodiazepine, R-L3 (L-364,373) , that is a stereospecific activator of cardiac I Ks .
Experimental Procedures
Isolation of guinea pig ventricular myocytes. Guinea pig ventricular myocytes were isolated as described previously . After isolation, the cells were stored in HBS containing 132 mM NaCl, 4 mM KCl, 1.8 mM CaCl 2 , 1.2 mM MgCl 2 , 10 mM HEPES, and 10 mM glucose, pH 7.2, at 24-26°until studied, usually within 8 hr after isolation.
Action potential studies. Transmembrane potentials were recorded using conventional microelectrodes filled with 3 M KCl (tip resistances, 30-50 M⍀) using an Axoclamp 2B amplifier (Axon Instruments, Foster City, CA) as described previously (Fermini et al., 1995) . Cells were superfused with HBS maintained at 37°at a rate of 2 ml/min APs were evoked with brief current pulses (1 msec, 1.2 times threshold) delivered at a frequency of 1 Hz through the recording electrode using an active bridge circuit. Only cells showing normal AP configurations and resting membrane potentials equal to or more negative than Ϫ85 mV were used in this study. Cells were studied after a Ն5-min control period and after Ն5 min of superfusion with each concentration of drug. After reaching a steady state effect under each condition, 20 individual APs were sampled and digitally averaged. The APA 50ms and APD 90 were measured from the digitally averaged records. Concentration-response relationships were determined by measuring APs or currents in each cell under control conditions and during superfusion with successively increasing concentrations of a given drug.
Voltage-clamp of guinea pig ventricular myocytes. Wholecell voltage-clamp studies were performed using a List EPC-7 (Medical Systems, Greenvale, NY) or Axopatch 200A (Axon Instruments) amplifier as described previously (Fermini et al., 1995) . Pipettes were made from square bore (1.0 mm outer diameter) borosilicate capillary tubing (Glass Company of America, Bargaintown, NJ). Pipettes were filled with 0.5 M K ϩ gluconate, 25 mM KCl, and 5 mM K 2 ATP to minimize "rundown" (Giles and Shibata, 1985) and had resistances of 3-7 M⍀ (average, 5.5 Ϯ 0.3 M⍀). Series resistance was compensated 40-70%. Currents were low-pass filtered (Ϫ3 dB at 0.2 kHz) before digitization at 1 kHz. I Ks was measured during superfusion of the cells at a rate of 2-3 ml/min with normal HBS (35°) containing 0.4-1 M nisoldipine to block L-type Ca 2ϩ current and standard selective I Kr blockers in 100-fold excess of the IC 50 (e.g., 3M MK-499) to completely block I Kr . Cells were voltage clamped at a V h of Ϫ50 mV to inactivate I Na . Time-dependent I Ks amplitude was measured as the difference from the initial instantaneous current, after the settling of the capacity transient, to the final current level at the end of a depolarizing pulse. I Ktail was measured as the difference from the holding current level to the peak tail current amplitude on return to V h . I Ktail was normalized to the maximum measured amplitude (I Ktail-max ) after 7.5-sec pulses. Averaged data were fit to a Boltzmann distribution of the form: I Ktail /I Ktail-max ϭ 1/(1 ϩ exp[(V 1/2 Ϫ V t )/k]) with a nonlinear least-squares fitting routine (Origin; Microcal Software, Northampton, MA) to estimate the half-point (V 1/2 ) and slope factor (k) for this relationship. The time courses of I Ks activation and deactivation were fit with a double exponential relationship of the form: I t ϭ A 0 ϩ A 1 e Ϫt/ 1 ϩ A 2 e Ϫt/ 2 using a Chebeshev noniterative fitting technique (pCLAMP; Axon Instruments).
I Ca was recorded using external and internal (pipette) solutions designed to minimize currents through Na ϩ and K ϩ channels and reduce rundown (Xu and Lee, 1994) . Cells were superfused with a solution containing 157 mM TEACl, 5 mM CaCl 2 , 0.5 mM MgCl 2 , and 10 mM HEPES, pH adjusted to 7.4 with CsOH (24-26°). Microelectrodes were fashioned from borosilicate capillary tubing (1.5 mm absorbance and filled with the following solution: 151 mM CsOH, 10 mM L-aspartic acid, 20 mM taurine, 20 mM TEACl, 10 mM EGTA, and 5 mM glucose, pH adjusted to 7.5 with H 3 PO 4 ; 0.4 mM Na 2 GTP and 5 mM MgATP were added just before use. The filled pipettes had resistances ranging from 2 to 4 M⍀. Series resistance was compensated by 80%. Because we did not observe bimodal I-V relations in our experiments, T-type Ca 2ϩ channels most likely contributed negligible current; therefore, the I Ca measured in the current study was considered to be L-type Ca 2ϩ current. Culture and voltage clamp of AT-1 cells. The original mouse atrial tumor (AT-1) mouse colonies were established by Dr. Loren Field (Krannert Institute of Cardiology, Indianapolis, IN) (Field, 1988) , and the lineage at Merck Research Laboratories was established from tumor cells that were provided by Dr. Dan Roden (Vanderbilt University, Nashville, TN). AT-1 cells were propagated in vivo, and their isolation and culturing were conducted as described previously (Delcarpio et al., 1991; Yang et al., 1994; Jurkiewicz et al., 1996) .
For voltage-clamp studies, AT-1 cells were trypsinized to remove them from the culture dishes and stored in PC-1 culture medium (22-24°). Outward K ϩ currents were recorded in normal HBS at 22-24°using standard whole-cell voltage-clamp techniques within 14 hr of isolation. Pipettes were filled with a solution containing 110 mM KCl, 5 mM K-BAPTA, 5 mM K 2 ATP, 1 mM MgCl 2 , and 10 mM HEPES, pH 7.2, and had resistances of 3-7 M⍀ (average, 5.5 Ϯ 0.3 M⍀). All cells were round in appearance, had large outward tail currents and resting membrane potentials (RMP) negative to Ϫ35 mV, and did not beat spontaneously. I Na and T-type calcium currents were inactivated by voltage-clamping the cells to a V h of Ϫ40 mV. I Ca was blocked with 0.4 M nisoldipine.
cRNA injection and voltage-clamp of oocytes. The isolation and maintenance of X. laevis oocytes, in vitro transcription of Kv-LQT1 and hminK cRNA, and its injection into oocytes were performed as described previously (Sanguinetti et al., 1995 (Sanguinetti et al., , 1996b . Stage V and VI oocytes were injected with 11.5 ng of KvLQT1 cRNA (46 nl of a 250 ng/l solution) alone or coinjected with 11.5 ng of KvLQT1 plus 1.25 or 0.1 ng of hminK cRNA. Currents were recorded 2-4 days later using standard two-microelectrode voltage-clamp techniques and a Dagan TEV-200 amplifier. Oocytes were bathed at room temperature (22-25°) in a solution containing 94 mM NaCl, 2 mM KCl, 2 mM MgCl 2 , 0.1 mM CaCl 2 , and 5 mM HEPES, pH 7.6.
Materials. R-L3 ( Fig. 1 ) was prepared as described previously by Evans et al. (1987) . Its enantiomer, S-L3, was prepared by the same procedure described for R-L3, with L-tryptophan acid chloride hydrochloride used in place of the D-isomer: 
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Compounds were dissolved in dimethylsulfoxide at a stock concentration of 1 or 10 mM and diluted directly into test solutions. Serial dilutions were used to achieve the final test concentrations. Dimethylsulfoxide at the concentrations used had no significant effect on any of the parameters measured in these studies. Nisoldipine (a gift from Miles Pharmaceuticals, New Haven, CT) was prepared as a 4 mM stock solution in dimethylsulfoxide and diluted as needed.
Statistics. Data are expressed as mean Ϯ standard error. Concentration-dependent changes in AP parameters and individual ionic currents were assessed by repeated-measures analysis of variance. Post hoc comparison of the treatment with the control mean values were made with Dunnett's t test to determine significant changes between the control and test group mean values. Statistical comparisons for the time constants of I Ks activation and deactivation were made using a paired t test. A one-tailed probability ( p Ͻ 0.05) was considered significant.
Results
R-L3 decreases APD of cardiac myocytes. R-L3 (0.1-1.0 M) caused a concentration-dependent shortening of APD. Fig. 2A shows a representative example of APs recorded at a stimulus frequency of 1 Hz. R-L3 significantly decreased APD 50 and APD 90 without significantly affecting other AP parameters (Table 1) . Shortening of APD was maximal at 1 M; APD 90 was decreased at concentrations of 1 and 10 M R-L3 by 14.2 Ϯ 1.6% and 13.8 Ϯ 4.0%, respectively.
Stimulation of ␤-adrenergic receptors can also shorten APD of cardiac myocytes (Carmeliet and Vereecke, 1969; Sanguinetti et al., 1991) . Therefore, we determined whether the decrease in APD by R-L3 was mediated through the same or parallel pathway. At a concentration of 30 nM, Iso decreased APD 90 by 12.9 Ϯ 2.9%. Iso also increased APA 50ms by 6.6 Ϯ 2.9% ( Fig. 2B) , presumably by enhancement of L-type Ca 2ϩ current (Kass and Wiegers, 1982) . The addition of 1 M R-L3 in the presence of 30 nM Iso decreased APD 90 further (26.9 Ϯ 1.4%) and diminished the increase in APA 50ms . Block of ␤-adrenergic receptors with 100 nM timolol did not alter configuration (Fig. 2C ) but prevented the effects of 30 nM Iso (data not shown). In the continued presence of timolol, the addition of 1 M R-L3 decreased APD 90 by 14.6 Ϯ 2.2%, very similar to the effect observed as in the absence of timolol. Thus, the decrease in APD by R-L3 is additive to the effect mediated by ␤-adrenergic stimulation.
R-L3 increases I Ks of guinea pig myocytes in a concentration-dependent and stereospecific manner. R-L3 is structurally related to L-735,821, a benzodiazepine that selectively blocks I Ks and prolongs APD of guinea pig ventricular myocytes . Therefore, we reasoned that R-L3 might shorten APD of guinea pig myocytes by activating I Ks .
The effect of R-L3 on I Ks was measured under voltageclamp conditions using 3-sec depolarizations to a test potential (V t ) of Ϫ10 mV from a V h of Ϫ50 mV (Fig. 3A) . In contrast to the previously reported effect of L-735,821, R-L3 increased I Ks . R-L3 enhanced I Ks measured at Ϫ10 mV at concentrations as low as 30 nM and had a maximal effect at 1 M. At this concentration, I Ks was increased by a factor of 17 Ϯ 5 (six cells). At a concentration of 3 or 10 M, the percentage increase in I Ks by R-L3 was less than that observed for 1 M (Fig. 3B ). This diminished response at high concentrations was caused by a time-and voltage-dependent block of I Ks that was most obvious during long pulses. For example, I Ks was increased by 10 M R-L3 during the first few seconds of a 7.5-sec pulse to ϩ50 mV. However, when the depolarization exceeded ϳ3 sec, the current measured in the presence of R-L3 was reduced compared with control (Fig. 3C ). R-L3 increased time-dependent I Ks at the end of 7.5-sec pulses to potentials Ͻϩ10 mV but decreased I Ks at more positive potentials (Fig. 3D) . Thus, the biphasic concentration-response relationship for the effects of R-L3 on I Ks for 3-sec pulses to Ϫ10 mV (Fig. 3B ) reflects the dual effects of the drug: activation that predominates at low concentrations and voltagedependent block at higher concentrations.
The increase of I Ks by R-L3 was stereospecific. S-L3 blocked I Ks at all concentrations (1-10 M) and test potentials (Ϫ10 to ϩ50 mV) examined. At concentrations of 1 and 10 M, S-L3 blocked I Ks measured at the end of a 1-sec test pulse to ϩ50 mV by an average of 14.8 Ϯ 4.3% and 68.8 Ϯ 3.4% (five cells). The voltage dependence of I Ks activation was estimated using 7.5-sec depolarizing steps from a V h of Ϫ50 mV (Fig. 4A) . The amplitude of the tail currents was normalized relative to the maximum amplitude and fit to a Boltzmann function (Fig. 4B) . Because I Ks does not achieve a steady state, even during extremely long pulses (Hice et al., 1994) , the activation curves are isochronal. In control, the V 1/2 was 19.2 Ϯ 1.6 mV, and k for this relationship was 11.0 Ϯ 1.2 mV (five cells). In these same cells, R-L3 shifted V 1/2 to 3.0 Ϯ 0.8 mV at 0.1 M and Ϫ4.9 Ϯ 3.4 mV at 1 M but had no effect on k. The maximally activated I Ks measured at a V t of ϩ60 mV (896 Ϯ 196 versus 953 Ϯ 183 pA, 1 M) was slightly but not significantly increased by R-L3. Likewise, after pretreatment with 100 nM timolol, 1 M R-L3 shifted the V 1/2 by Ϫ19 mV without affecting k, indicating that its effect was independent of ␤-adrenergic stimulation. These results suggest that the primary mechanism of the increase in I Ks by R-L3 is an effect on channel gating.
The onset of I Ks activation, after a short delay, was best described by a two-exponential function. The fast time constants of activation were slightly, but not significantly, faster in the presence of 1 M R-L3. This effect was likely due to the negative shift in the voltage dependence of channel activation. In contrast to the modest effect on the kinetics of activation, R-L3 greatly slowed the rate of I Ks deactivation (Fig.  4A) . The kinetics of deactivation were determined at potentials of Ϫ60 to Ϫ10 mV after a 3-sec prepulse to ϩ30 mV from a V h of Ϫ50 mV. The deactivation of I Ks was best described by a two-exponential function before and after the addition of R-L3. R-L3 significantly increased the fast ( fast ) and the slow ( slow ) time constants of deactivation (Fig. 5) . The slowing of molpharm.aspetjournals.org the rate of deactivation by R-L3 represents an additional mechanism that would increase outward current during repolarization of a cardiac AP. R-L3 activates I Ks independent of ␤-adrenergic receptor activation. I Ks was activated by 0.5-sec pulses to a V t ranging from Ϫ40 to ϩ50 mV. Iso (10 nM) alone increased I Ks by 1.75-fold. The addition of 1 M R-L3 produced a further increase in I Ks , slowed the rate of deactivation, and shifted the threshold for current activation to more negative potentials (Fig. 6) . The effects of R-L3 persisted after washout of the Iso. Similar effects were observed when exposure of cells to R-L3 preceded the addition of Iso. Thus, similar to the decrease in APD caused by R-L3, the increase in I Ks by R-L3 was additive to that caused by ␤-adrenergic receptor stimulation.
R-L3 activates cloned human KvLQT1 channels expressed in X. laevis oocytes. At a concentration of 1 M, R-L3 increased KvLQT1 elicited with 2-sec pulses to potentials ranging from Ϫ70 to ϩ60 mV (Fig. 7, A and B) . This increase can partially be accounted for by a Ϫ10-mV shift in the voltage dependence of activation caused by the drug (Fig.  7C) . R-L3 also slowed the kinetics of KvLQT1, an effect that is easily observed when the time-dependent currents recorded before and after exposure to 1 M R-L3 are superimposed and scaled to match peak current (Fig. 8A) . Activation of KvLQT1 current is best described by a two-exponential function. The effect of R-L3 on these two components varied with V t . R-L3 slowed the rate of the fast component at V t Ն0 mV (Fig. 8B) , but increased the rate of the slow component of activation at V t ՆϪ30 mV (Fig. 8C) . The net effect of R-L3 was to slow the rate of KvLQT1 activation because of a reduction in the relative amplitude of the fast component of activation over the entire voltage range that was examined (Fig. 8D) . R-L3 also slowed the rate of KvLQT1 deactivation when assessed at voltages negative to Ϫ40 mV (Fig. 8E) . Thus, R-L3 increased the magnitude of KvLQT1, shifted the voltage dependence of its activation, and slowed the rates of activation and deactivation. These effects of R-L3 on KvLQT1 current are similar to those observed for I Ks recorded in guinea pig ventricular myocytes.
R-L3 activates cloned human I Ks currents depending on hminK/KvLQT1 ratio. I Ks currents are formed by coassembly of KvLQT1 and minK subunits (Barhanin et al., 1996; Sanguinetti et al., 1996b) . Therefore, in addition to its effects on KvLQT1 channels, we determined the effects of R-L3 on KvLQT1 plus hminK (I Ks ) currents expressed in X. laevis oocytes. When oocytes were injected with 11.5 ng of KvLQT1 and 1 ng of hminK cRNAs, amounts similar to previous studies, we expected to observe an increase in the magnitude of cloned I Ks similar to that described above for I Ks recorded from guinea pig myocytes. Surprisingly, we found that R-L3 had no obvious effect on channels formed by coassembly of KvLQT1 plus hminK (Fig. 9) . The only statistically significant effect of the drug was a slowing of the rate of deactivation. At Ϫ50 mV, deactivation was 470 Ϯ 18 msec in control and 507 Ϯ 12 msec after 1 M R-L3 ( p Ͻ 0.05). We observed Fig. 4 . R-L3 shifts the voltage-dependence of I Ks activation in guinea pig isolated ventricular myocytes. A, Currents recorded at the indicated V t before (control) and after the addition of 1 M R-L3. B, Isochronal activation curves were determined from the normalized amplitudes of tail currents after 7.5-sec pulses. Data were fitted to a Boltzmann function to determine the V 1/2 and slope factor (k) for the relationship. The V 1/2 was 19.2 Ϯ 1.6 mV in control and 3.0 Ϯ 0.8 mV and Ϫ4.9 Ϯ 3.4 mV at 0.1 and 1.0 M R-L3, respectively (five cells). The k value was 11.0 Ϯ 1.2 mV in control and was not significantly changed by R-L3. a similar lack of effect of R-L3 on expressed I Ks when either human or guinea pig minK cRNA alone was injected into X. laevis oocytes (data not shown), Presumably, these currents represent channels formed from coassembly of exogenous minK and endogenous KvLQT1. These data indicate that association of KvLQT1 with minK subunits prevents the activation of channel activity by R-L3 that occurs when only KvLQT1 channels are overexpressed in oocytes.
To test this hypothesis further, the ratio of hminK/Kv-LQT1 subunits was reduced by injecting oocytes with 11.5 ng of KvLQT1 and 0.1 ng of hminK cRNA. Under these conditions (Fig. 10) , the induced current activated at a rate faster than I Ks but slower than KvLQT1 alone (compare with Figs. 7 and 9), suggesting that not all channels were heteromultimeric. In this case, R-L3 caused an increase in current in all cells (seven cells). On average, R-L3 increased peak outward current by 28% at ϩ40 mV.
R-L3 blocks I Kr and I Ca but not I K1 . To determine the selectivity of R-L3, we measured its effects on three other currents, I Kr , I K1 , and I Ca , that modulate cardiac APD.
I K1 and I Ca were measured in guinea pig isolated ventricular myocytes. R-L3 at 10 M had no significant effect on I K1 . For example, I K1 at Ϫ60 mV was 5.5 Ϯ 1.1 pA/pF in control and 5.7 Ϯ 1.2 pA/pF after the addition of R-L3 (five cells). R-L3 had no significant effect on I Ca at 1 M, but at 10 M it reduced peak I Ca at ϩ20 mV by 43.6 Ϯ 6.6% (nine cells; Fig.  11 ). The block of I Ca was not use-dependent. In two cells, block of I Ca by 10 M R-L3 during trains of 30 pulses applied to ϩ20 mV at rates of 1 and 3 Hz initially was 57% and 61%, respectively, and was unchanged (59% and 60%) at the end of the pulse trains.
Because R-L3 caused a negative shift in the voltage-dependence of I Ks activation, I Kr could not satisfactorily be measured in isolation from I Ks in guinea pig myocytes. Therefore, the effects of R-L3 on I Kr was determined in mouse AT-1 myocytes (Fig. 12) . These cells have a large I Kr but no measurable I Ks (Yang et al., 1994) . R-L3 blocked I Kr tail currents after a 1-sec test pulse to ϩ20 mV by 21 Ϯ 6% and 53 Ϯ 3% (three cells) at concentrations of 1 and 10 M, respectively.
Discussion
At concentrations of Յ1 M, R-L3 shortened APD of cardiac myocytes by selective activation of I Ks . At membrane potentials and pulse durations typical for a cardiac AP, the most important mechanisms of action of R-L3 were a negative shift Fig. 6 . Effects of Iso and R-L3, alone and in combination, on the I-V relationship of I Ks in guinea pig isolated ventricular myocytes. A, Traces were recorded during control, after exposure to 10 nM Iso alone, and after the addition of 1 M R-L3 and then after washout of Iso but in the continued presence of R-L3. Currents were elicited by 0.5-sec pulses from a V h of Ϫ50 mV. B, I-V relationship for time-dependent I Ks for each condition (five cells). Fig. 7 . R-L3 activates cloned KvLQT1 channels expressed in X. laevis oocytes. A, Currents were measured in response to 2-sec pulses from a V h of Ϫ80 mV to a V t of Ϫ60 mV to ϩ40 mV, applied in 20-mV increments. Tail currents were measured at Ϫ70 mV. B, I-V relationships for peak KvLQT1 current during 2-sec pulses to the indicated test potential before and after 1 M R-L3. C, Voltage dependence of KvLQT1 activation. Tail current amplitudes were determined from extrapolating a single exponential fit of deactivating currents to the onset of membrane repolarization. Isochronal activation curves were determined by fitting normalized tail current amplitudes to a Boltzmann function. In control, the V 1/2 was Ϫ28 mV and the slope factor (k) was 11 mV for this relation. In the presence of 1 M R-L3, the V 1/2 was -40 mV and k was 13 mV (eight cells). in the voltage dependence of activation and a slowing of I Ks deactivation. R-L3 also caused a modest increase in I Ks beyond what could be explained by these two mechanisms. The molecular mechanism of these effects on I Ks current-gating is not known, but it is not mediated through the ␤-adrenergic receptor activation pathway.
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At concentrations of Ͼ1 M, the effect of R-L3 on APD would reflect multiple mechanisms, including activation of I Ks (especially at potentials of Ͻ0 mV), block of I Kr , and block of L-type I Ca . Block of I Kr would lengthen APD, whereas block of I Ca would contribute to a shortening of APD. Because APD 90 was unchanged, whereas APD 50 was further short- . R-L3 does not activate cloned I Ks currents expressed in X. laevis oocytes. A, Currents recorded in an oocyte during 7.5-sec pulses applied to V t between Ϫ20 mV and ϩ40 mV. Oocyte was injected with 11.5 ng of KvLQT1 and 1 ng of hminK cRNAs, and currents were recorded in control and 7 min after the addition of 1 M R-L3. B, I-V relationships for peak currents (eight cells). Fig. 10 . R-L3 activates current induced by injection of KvLQT1 and hminK cRNAs when amount of minK cRNA is limiting. A, Currents recorded in an oocyte during 7.5-sec pulses applied in 20-mV increments to a V t between Ϫ40 and ϩ40 mV. Oocyte was injected with 11.5 ng of KvLQT1 and 0.1 ng of hminK cRNAs, and currents were recorded in control and 7 min after the addition of 1 M R-L3. B, I-V relationships for peak currents (seven cells).
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؉ Current ened and the plateau height (APA 50ms ) was reduced when R-L3 was increased from 1 to 10 M, it is likely that the block of I Ca was more important than the block of I Kr at 10 M in guinea pig ventricular myocytes. A high concentration (10 M) of R-L3 also caused a block of I Ks after long pulses to very positive potentials. However, even at 10 M, R-L3 would be expected to cause only an increase in I Ks during the limited time of depolarization of a cardiac AP. We could not test the effects of R-L3 at concentrations of Ͼ10 M because of its limited aqueous solubility. We compared and contrasted the effects of R-L3 and Iso on configuration. These studies revealed a similar shortening of APD 90 but other important differences, especially on plateau height. Effects of ␤-adrenergic receptor stimulation on APs are difficult to interpret because of the multitude of effects on ion channels and pumps. Nevertheless, the persistent effects of R-L3 in the presence of timolol, a ␤-adrenergic receptor blocker, demonstrate that its effects are not mediated via this signaling pathway.
The findings that R-L3 activated I Ks at low concentrations but blocked I Ks at high concentrations, as did the S-enantiomer, suggest that there may be multiple binding sites for L-3 on the I Ks channel. Multiple binding sites have been proposed to explain the dual action of dihydropyridines such as Bay K 8644 on the L-type Ca 2ϩ channel (Brown et al., 1986; Kokubun et al., 1986) .
R-L3 increased the magnitude of cloned KvLQT1 current, but its activation of human I Ks channels formed by coassembly of KvLQT1 and hminK subunits depended on their ratio. When minK and KvLQT1 were coexpressed at relatively high ratio, such that the expression of minK was not limiting, R-L3 had no significant effect on I Ks . However, when coexpressed at a 10-fold lower ratio, where minK was limiting, R-L3 increased I Ks. The resulting currents at the low minK/ KvLQT1 ratio were larger and activated at a rate slower than that of the current induced by KvLQT1 alone but were faster than those induced by the high subunit ratio. The stoichiometry of I Ks channels is unknown. Because KvLQT1 alone or coexpressed with minK can form functional channels, it may be possible for minK subunits to coassemble with individual KvLQT1 subunits or KvLQT1 tetramers in variable ratios Fig. 11 . R-L3 blocks I Ca in guinea pig isolated ventricular myocytes at 10 M. I Ca was measured at room temperature during 100-msec pulses from a V h of Ϫ50 mV to V t between Ϫ40 and ϩ60 mV during control and after the addition of 1 and 10 M R-L3. Fig. 12 . R-L3 blocks I Kr in AT-1 cells. Currents were measured at room temperature during 1-sec pulses from a V h of Ϫ40 mV to V t between Ϫ30 and ϩ50 mV during control and after the addition of 1 and 10 M R-L3. and thereby impart differing biophysical characteristics and pharmacological sensitivity. Alternatively, there may be only one functional I Ks channel type with a fixed stoichiometry of KvLQT1 and minK subunits, and these may coexist in variable ratios with KvLQT1 homotetramers. A clearer understanding of this stoichiometry may help to explain why the effects of the drug on guinea pig I Ks are better mimicked by cloned KvLQT1 channels, whereas the biophysical properties of I Ks are more closely mimicked by channels formed by coassembly of KvLQT1 ϩ hminK. Nevertheless, these findings indicate that the binding site for R-L3 is located on the KvLQT1 subunit and that coassembly with hminK diminishes or abolishes the agonist activity of R-L3. These studies are consistent with, but not proof of, the ideas that minK and R-L3 bind to a common region of KvLQT1 subunits and that association of minK with KvLQT1 precludes the drug-induced alteration of gating kinetics observed when only KvLQT1 channels are overexpressed in oocytes. Regardless of the exact mechanism, these findings suggest the possibility that I Ks recorded in cardiac myocytes represents the sum of current mediated by KvLQT1 homotetrameric channels and heteromultimeric channels formed by coassembly of Kv-LQT1 plus minK subunits.
This and all studies of I Ks face the same possible limitations, including the potential for K ϩ accumulation during long depolarizing pulses (Boyett et al., 1980 , but see also Sanguinetti and Jurkiewicz, 1990 ), a lack of steady state activation of I Ks , and interference or overlap with other cardiac currents. Our voltage-clamp protocols and conditions were designed to reduce or eliminate these concerns. To measure activation of I Ks channels, relatively long pulse durations of 7.5 sec were used as in previous studies (Sanguinetti and Jurkiewicz, 1990) to approach steady state activation, whereas longer pulses were avoided to minimize the potential for K ϩ accumulation. I Kr blockers were used in excess (100 ϫ IC 50 values at 4 mM [K ϩ ] o ) to completely block I Kr . Although an increase in [K ϩ ] o has been reported to decrease the potency of I Kr blockers (e.g., dofetilide; (Yang and Roden, 1996) , the 100-fold excess used to block I Kr in this study would not be overcome by potential elevations of [K ϩ ] o . Most currents other than I Ks were also eliminated by pharmacological blockade or inactivation (or both) with V h .
A drug that activates I Ks could be beneficial for the treatment of certain arrhythmias. The proarrhythmic potential of class III antiarrhythmic drugs that block I Kr prompted the search for agents that would produce more modest prolongation of APD at high doses. The proarrhythmic liability associated with block of I Kr currents was recently confirmed by the finding that mutations in HERG, the gene encoding I Kr channel subunits, can cause inherited LQT . Recently, I Ks blockers have been described that lengthen APD and have antiarrhythmic effects in animal models. Chromanol 293B (Busch et al., 1996) and the more potent L-735,821, a 1,4-benzodiazepine , inhibit I Ks and cause a self-limiting prolongation of APD that is less than that produced by I Kr blockers. However, mutations in KvLQT1 can also cause inherited LQT Neyroud et al., 1997) . This latter finding could dampen enthusiasm for the development of I Ks blockers for prophylactic treatment of ventricular tachyarrhythmias. If I Kr or I Ks blockers are used as antiarrhythmic drugs, it would be useful to have a channel activator that could reverse the effects of overdose. Moreover, pharmacological activation of I Ks might also be useful for treatment of inherited LQT and abnormally delayed repolarization associated with heart failure (Beuckelmann et al., 1993; Tomaselli et al., 1994) . In summary, we described the properties of R-L3, a novel benzodiazepine that selectively activates I Ks in myocytes at low concentrations. This compound represents a new pharmacological probe for the study of I Ks in cardiac myocytes. In addition, R-L3 can be used as a probe to define the physiological role of I Ks and KvLQT1 currents in other tissues, such as the pancreas and stria vascularis of the inner ear (Neyroud et al., 1997) .
